+32.6%
PYPL vs EMR
+250.9%
-218.3%
-87.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.5% | -4.2% | -1.2% | -3.6% |
| 7D | -10.1% | -9.3% | -0.8% | -6.1% |
| 30D | -6.8% | -7.1% | +0.3% | -3.8% |
| 3M | -14.3% | -2.1% | -12.2% | -13.6% |
| 6M | +20.8% | +14.4% | +6.4% | +12.6% |
| YTD | -7.9% | +15.4% | -23.3% | -16.1% |
| 1Y | -7.5% | +23.8% | -31.3% | -18.6% |
| 3Y | -5.4% | +78.8% | -84.2% | -31.2% |
| 5Y | -72.2% | +78.2% | -150.4% | -80.0% |
| All | +32.6% | +250.9% | -218.3% | -30.5% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling